Supplier · Peer benchmark
Peer comparison
How GlaxoSmithKline Biologicals S.A stacks up against suppliers competing for the same workloads — based on overlap with its 1 signature CPV code over the last 24 months.
Value band:
/
CohortGlaxoSmithKline Biologicals S.A(You)Aventis Pharma Limited T/a SanofiERAMOL (UK) LTDAllianceMasta LtdAl-Haya Medical Company
iAuto-picked from 1 signature CPV code · last 24 months overlap
Metric | AP Aventis Pharma Limited T/a Sanofi Peer · rank #1 | GB GlaxoSmithKline Biologicals S.A (You) · target supplier | E( ERAMOL (UK) LTD Peer · rank #3 | AL Alliance Peer · rank #4 | MA Masta Ltd Peer · rank #5 | AM Al-Haya Medical Company Peer · rank #6 |
|---|---|---|---|---|---|---|
01ActivityVolume, scale, freshness | ||||||
| 12-month contractedAward value, last 12m | £43k | — | — | — | — | — |
| Framework headroomPer-supplier share of framework ceilings | — | — | — | — | — | — |
| Total awarded (lifetime)All time, all contracts | £32.8m | £0.5(−100%) | £2.4m | £132.5m | £2.1m | £49k |
| Contracts won (12m)Distinct awards last year | 3 | — | 1 | — | 1 | |
How to read a target cell
The target column carries a delta — value compared to the peer median for that row. Direction-of-good varies by metric, so deltas are neutral.
Peer cell£499m(peer median £255m)
→
Target cell£11.7m(−97% vs median)
Money:
£N.Nm, £Nk, £N.NbnPercent: 42% · pp delta: (+12pp)Day delta: (−149 days) · missing: —